Professor Mitch Dowsett honoured with Brinker Award for Scientific Distinction

Professor Dowsett will receive the Susan G. Komen Brinker Award for Scientific Distinction in Clinical Research.

The awarding body praised his "seminal contributions in understanding the hormonal basis of oestrogen receptor (ER) positive breast cancer, and translating this knowledge to the clinic in order to improve the efficacy of treatment and prevention of breast cancer.

His translational approach to studying the endocrine aspects of breast cancer and biomarkers for breast cancer prognosis and treatment has led to the implementation of key treatments and identification of tumour markers that have advanced breast cancer care."

Dr George Sledge, one of Komen’s Chief Scientific Advisors, said: “Professor Dowsett has been a leader in the application of cutting-edge science to large clinical data sets. His leadership of several important translational studies in both the adjuvant and neoadjuvant settings has transformed our understanding of oestrogen receptor positive breast cancer, improving our knowledge regarding prognosis and therapeutic benefit.”

The Brinker Awards for Scientific Distinction were established in 1992 to recognize the efforts of pioneers in two critically important areas of the fight to end breast cancer: Clinical Research and Basic Science.

Professor Dowsett will deliver a keynote lecture on 10 December at the 37th annual San Antonio Breast Cancer Symposium, a major international gathering of breast cancer researchers, clinicians, and patient advocacy organisations from around the world.

Find out more

For more information about this or any other news story, contact The Royal Marsden Press Office.